Major Shareholder Investigation on Mergers of Leading Companies in 2026

Shareholder Alert: Investigation of Major Mergers

In the dynamic world of business and finance, the integrity of mergers can significantly impact shareholders' wealth. Recent investigations spearheaded by Monteverde & Associates, known as the M&A Class Action Firm, shed light on several notable corporate transactions, focusing on the interests of stockholders. The firm, recognized for its successful track record, is currently probing four substantial mergers:

1. Arcosa, Inc. (NYSE: ACA) - Arcosa's prospective sale to CRH Americas, Inc. promises a cash payout of $150.00 per share to shareholders. This merger has raised questions about the fairness of the valuation and the implications for shareholders.

2. Apogee Therapeutics, Inc. (NASDAQ: APGE) - This company is exploring a sale to AbbVie Inc., with an anticipated share price of $135.11 per share in cash, prompting scrutiny over whether shareholders are getting a fair deal.

3. Boundless Bio, Inc. (NASDAQ: BOLD) - Facing a merger with Serapha Bio, Inc., current shareholders stand to retain approximately 3.7% stake in the new combined entity post-transaction. This merger's intricacies raise concerns about the equity for current stockholders in the emergent corporate structure.

4. Selectis Health, Inc. (OTCMKTS: GBCS) - Negotiations regarding the sale to Black Pearl Equities II, LLC hinge on a $5.75 per share cash offer, a figure that needs thorough examination for validity and benefit to shareholders.

The drive for better shareholder outcomes continues to be a priority for the firm as it offers no-cost consultations to affected individuals, emphasizing an obligation-free opportunity to discuss potential grievances related to these transactions. Juan Monteverde, the mastermind behind this initiative, advocates for shareholder rights and transparency, ensuring that no executive or company can manipulate proceedings without accountability.

Monteverde & Associates, headquartered in the iconic Empire State Building in New York City, brings a wealth of experience in advocating for shareholders, having successfully recovered millions in class action suits across various industries. Rankings from the 2025 ISS Securities Class Action Services Report position the firm among the Top 50 in the sector, affirming its reputation.

As the investigations develop, shareholders of ACA, APGE, BOLD, and GBCS are encouraged to become proactive about their investments. Given the complexities surrounding mergers and acquisitions, understanding the implications of these transactions is crucial. Shareholders should consider reaching out to legal experts for guidance, especially before entering any agreements or transactions related to these companies. By doing so, they can ensure they are well-informed and adequately represented during these potentially transformative corporate changes.

While shareholder activism holds significant power in shaping corporate behavior, it requires diligence and collective action to influence outcomes positively. The current investigations signify a crucial moment in defending shareholder rights amidst corporate mergers, encouraging a shareholder-community response to ensure fair valuation and consideration in business dealings. As the financial landscape evolves, the importance of legal vigilance cannot be overstated, empowering shareholders in their quest for equity and accountability in corporate governance.